Alcohol consumption is an integral part of daily life in many societies. The benefits
associated with the production, sale, and use of alcoholic beverages come at an enormous …

A variety of evidence suggests that endogenous opioid peptides play a role in the short-term
control of eating. More recently, opioid receptor antagonists like naltrexone have been …

The goal of this guideline1 is to improve the quality of care and treatment outcomes for
patients with alcohol use disorder (AUD), as defined by DSM-5 (American Psychiatric …

Background: This laboratory study investigated the mechanisms by which the opioid
antagonist, naltrexone, reduces the risk of relapse to heavy drinking in individuals with …

Context Medication for the treatment of alcoholism is currently not particularly robust.
Neuroimaging techniques might predict which medications could be useful in the treatment …

The goal of this review is to familiarize the reader about the potential involvement of the
brain reward system (BRS) in symptoms of Major Depressive Disorder (MDD). The authors …

Although far from conclusive, evidence implicating the endogenous opioid system in the
development and maintenance of alcoholism is growing. Currently available data suggest …

There is increasing evidence supporting a link between the endogenous opioid system and
excessive alcohol consumption. Acute or light alcohol consumption stimulates the release of …

People with alcohol use disorders often have co-occurring psychiatric disorders, but they
frequently do not receive specialized substance abuse treatment that addresses both …

Over the last 20 years, the role of adjuvant pharmacotherapy in optimising outcome in
rehabilitation programmes for alcohol-dependent patients has become increasingly evident …